Related Experiment Video
Updated: Jun 19, 2026

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
Th17 immunity in patients with allergic asthma
Yang Zhao1, Jiong Yang, Ya-Dong Gao
1Department of Respiratory Medicine, Zhongnan Hospital and Department of Respiratory Medicine, Renmin Hospital, Wuhan, China.
This study reveals that T helper 17 (Th17) cell immunity, alongside Th2 immunity, plays a role in allergic asthma pathogenesis. Increased Th17 cells and related cytokines correlate with asthma severity, suggesting new therapeutic targets.
Area of Science:
- Immunology
- Allergy Research
- Respiratory Medicine
Background:
- Allergic asthma is an inflammatory condition involving T helper (Th) cells.
- A Th1/Th2 imbalance is recognized in asthma pathogenesis.
- The role of Th17 cells in human allergic asthma systemic immunity remains unclear.
Purpose of the Study:
- To investigate the contribution of Th17 immunity to systemic immune responses in allergic asthmatic patients.
- To compare Th1, Th2, and Th17 cell frequencies and related cytokine levels in asthmatics versus healthy controls.
Main Methods:
- Flow cytometry was used to analyze Th1, Th2, and Th17 cell frequencies in peripheral blood mononuclear cells from 29 allergic asthmatics and 12 healthy controls.
- Enzyme-linked immunosorbent assay and Luminex measured cytokine concentrations (IFN-gamma, IL-4, IL-17, IL-22, IL-23, IL-25).
- Real-time quantitative polymerase chain reaction assessed retinoic acid-related orphan receptor gammat (RORgammat) levels.
Main Results:
- Allergic asthmatics showed higher percentages of Th2 and Th17 cells and elevated Th2/Th17 cytokine concentrations compared to controls.
- Th17 cell percentages and plasma IL-17 and IL-22 levels increased with asthma severity.
- Elevated IL-17 and IL-23 concentrations and increased RORgammat levels were observed in asthmatics.
Conclusions:
- Abnormal Th17 immunity, in addition to Th2 immunity, is implicated in the pathogenesis of allergic asthma.
- Findings suggest Th17-related pathways as potential targets for managing allergic asthma.
Related Concept Videos
Asthma I: Introduction
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma III: Clinical Manifestations

